Literature DB >> 11284562

A seven-year experience of data collection on the Insall-Burstein II total knee arthroplasty. A prospective study.

D I Rowley1, D W McGurty.   

Abstract

We describe a method of audit of a type of total knee replacement, including some details of the organisational difficulties of administering multicentre studies, and draw attention to how this can be done using industrial funding without prejudicing the study. This is a prospective record of 1439 patients who had an Insall-Burstein II (IBII) prosthesis implanted between 1990 and 1994. The data were collected using the American Knee Society scoring system. A method of storing radiographs digitally at low cost is also described. The results emphasise the need for the long-term collection of data on commonly used devices implanted by a cross-section of surgeons. We conclude that for most patients the IBII cemented, posteriorly stabilised, cruciate-substituting prosthesis will relieve pain and give excellent functional results throughout the patients' remaining years with a very small incidence of revision, except in cases of infection.

Entities:  

Mesh:

Year:  2001        PMID: 11284562     DOI: 10.1302/0301-620x.83b2.10959

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  3 in total

Review 1.  Implant survival of 3rd-condyle and post-cam posterior-stabilised total knee arthroplasty are comparable at follow-up > 10 years: a systematic review.

Authors:  David H Dejour; Jacobus H Müller; Mo Saffarini; Michel Timoteo; Pierre Chambat; Gerard Deschamps; Michel P Bonnin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-03-04       Impact factor: 4.342

2.  The Columbus Knee System: 4-Year Results of a New Deep Flexion Design Compared to the NexGen Full Flex Implant.

Authors:  D Goebel; W Schultz
Journal:  Arthritis       Date:  2012-03-07

3.  Early experience with the NexGen® CR-Flex Mobile knee arthroplasty system: results of 2-year follow-up.

Authors:  Stefan Endres; Axel Wilke
Journal:  Orthop Rev (Pavia)       Date:  2010-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.